Relevance of studying T cell responses in SIV-infected rhesus macaques

Laura E. Valentine, David Watkins

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

HIV infection, once established, is never cleared. Rare individuals do, however, control viral replication to low levels. These successful immune responses are primarily linked to certain class I MHC alleles (MHC-I). Because of this association, many AIDS vaccines in development are designed to generate virus-specific CD8+ T cells. The Merck STEP phase 2b efficacy trial of one such vaccine was recently halted, and declared a failure. Thus, basic questions regarding what constitutes an effective T cell response and how such responses could be elicited by vaccination remain open. The best animal model available to explore such issues is simian immunodeficiency virus infection of rhesus macaques, which serves as the primary proving ground for AIDS vaccines.

Original languageEnglish
Pages (from-to)605-611
Number of pages7
JournalTrends in Microbiology
Volume16
Issue number12
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

AIDS Vaccines
Macaca mulatta
T-Lymphocytes
Simian Immunodeficiency Virus
Virus Diseases
HIV Infections
Vaccination
Vaccines
Animal Models
Alleles
Viruses

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Microbiology
  • Virology

Cite this

Relevance of studying T cell responses in SIV-infected rhesus macaques. / Valentine, Laura E.; Watkins, David.

In: Trends in Microbiology, Vol. 16, No. 12, 01.12.2008, p. 605-611.

Research output: Contribution to journalArticle

@article{fd890c8509a54468851d2d9895c499d0,
title = "Relevance of studying T cell responses in SIV-infected rhesus macaques",
abstract = "HIV infection, once established, is never cleared. Rare individuals do, however, control viral replication to low levels. These successful immune responses are primarily linked to certain class I MHC alleles (MHC-I). Because of this association, many AIDS vaccines in development are designed to generate virus-specific CD8+ T cells. The Merck STEP phase 2b efficacy trial of one such vaccine was recently halted, and declared a failure. Thus, basic questions regarding what constitutes an effective T cell response and how such responses could be elicited by vaccination remain open. The best animal model available to explore such issues is simian immunodeficiency virus infection of rhesus macaques, which serves as the primary proving ground for AIDS vaccines.",
author = "Valentine, {Laura E.} and David Watkins",
year = "2008",
month = "12",
day = "1",
doi = "10.1016/j.tim.2008.08.010",
language = "English",
volume = "16",
pages = "605--611",
journal = "Trends in Microbiology",
issn = "0966-842X",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - Relevance of studying T cell responses in SIV-infected rhesus macaques

AU - Valentine, Laura E.

AU - Watkins, David

PY - 2008/12/1

Y1 - 2008/12/1

N2 - HIV infection, once established, is never cleared. Rare individuals do, however, control viral replication to low levels. These successful immune responses are primarily linked to certain class I MHC alleles (MHC-I). Because of this association, many AIDS vaccines in development are designed to generate virus-specific CD8+ T cells. The Merck STEP phase 2b efficacy trial of one such vaccine was recently halted, and declared a failure. Thus, basic questions regarding what constitutes an effective T cell response and how such responses could be elicited by vaccination remain open. The best animal model available to explore such issues is simian immunodeficiency virus infection of rhesus macaques, which serves as the primary proving ground for AIDS vaccines.

AB - HIV infection, once established, is never cleared. Rare individuals do, however, control viral replication to low levels. These successful immune responses are primarily linked to certain class I MHC alleles (MHC-I). Because of this association, many AIDS vaccines in development are designed to generate virus-specific CD8+ T cells. The Merck STEP phase 2b efficacy trial of one such vaccine was recently halted, and declared a failure. Thus, basic questions regarding what constitutes an effective T cell response and how such responses could be elicited by vaccination remain open. The best animal model available to explore such issues is simian immunodeficiency virus infection of rhesus macaques, which serves as the primary proving ground for AIDS vaccines.

UR - http://www.scopus.com/inward/record.url?scp=56649095805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56649095805&partnerID=8YFLogxK

U2 - 10.1016/j.tim.2008.08.010

DO - 10.1016/j.tim.2008.08.010

M3 - Article

C2 - 18964016

AN - SCOPUS:56649095805

VL - 16

SP - 605

EP - 611

JO - Trends in Microbiology

JF - Trends in Microbiology

SN - 0966-842X

IS - 12

ER -